Refine Results
  1. "2017"
  2. "Melanoma Disease Management Team"
Formats
  1. Journal Article (254)
  2. Meeting Abstract (78)
  3. Book Section (19)
  4. Book Whole (1)
  5. Conference Paper (1)
Groups
  1. Melanoma Disease Management Team (353)
  2. Survivorship Research (109)
  3. Head and Neck Cancer Disease Management Team (106)
  4. Surgery (103)
  5. Solid Tumor Oncology Division (92)
  6. Dermatology Service (91)

More Groups

People
  1. Jedd Wolchok (43)
  2. Nancy Lee (42)
  3. Klaus Busam (30)
  4. Mario Lacouture (23)
  5. Jennifer Hay (22)
  6. Ashfaq Marghoob (21)

More People

Years
  1. 2017 (353)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (23)
  2. Journal of the American Academy of Dermatology (15)
  3. JAMA Dermatology (10)
  4. Lentigo Maligna Melanoma: Challenges in Diagnosis and Management (10)
  5. Neuro-Oncology (10)
  6. Journal of Clinical Oncology (9)

More Publications

Publishers
  1. Elsevier Inc. (54)
  2. Springer (47)
  3. Nature Publishing Group (22)
  4. Wiley Blackwell (22)
  5. Lippincott Williams & Wilkins (21)
  6. Oxford University Press (20)

More Publishers

Results (353)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Esophageal tumors in childhood and adolescence: Benign and malignant
    Book Section

    Theilen, T. M.; La Quaglia, M.
    In Till, H.; Thomson, M.; Foker, J. E.; Holcomb, G. W. 3rd; Khan, K. M. (Eds.) Esophageal and Gastric Disorders in Infancy and Childhood (2017)

    Fulltext@MSK | Save
  • The debate against elective lymph node dissection in papillary thyroid carcinoma
    Book Section

    Nixon, I. J.; Shaha, A. R.
    In Mancino, A. T.; Kim, L. T. (Eds.) Management of Differentiated Thyroid Cancer (2017)

    Fulltext@MSK | Save
  • Ex vivo fluorescent confocal microscopy to guide micrographic Mohs surgery
    Book Section

    Longo, C.; Ragazzi, M.; Nehal, K.; Bennassar, A.; Malvehy, J.; Rajadhyaksha, M.
    In González, S. (Eds.) Reflectance Confocal Microscopy of Cutaneous Tumors. 2nd ed (2017)

    Fulltext@MSK | Save
  • Congenital melanocytic nevi
    Book Section

    Farnetani, F.; Carrera, C.; García, A. P.; Marghoob, A. A.
    In González, S. (Eds.) Reflectance Confocal Microscopy of Cutaneous Tumors. 2nd ed (2017)

    Fulltext@MSK | Save
  • Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma
    Journal Article

    Zuleger, C. L.; Kang, C.; Ranheim, E. A.; Kurzman, I. D.; Macklin, M. D.; Newton, M. A.; Wolchok, J. D.; Vail, D. M.; Eriksson, E.; Albertini, M. R.
    Veterinary Medicine and Science (2017)

    Fulltext@MSK | Save
  • Growth of uveal melanoma following intravitreal bevacizumab
    Journal Article

    Francis, J. H.; Kim, J.; Lin, A.; Folberg, R.; Iyer, S.; Abramson, D. H.
    Ocular Oncology and Pathology (2017)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel cy/flu/thio/TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A.; Maloy, M.; Mazis, C.; Naputo, K.; Scaradavou, A.; O'Reilly, R.; Avecilla, S.; Castro-Malaspina, H. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • PD-L1 is regulated by interferon gamma and interleukin 6 through STAT1 and STAT3 signaling in cutaneous T-cell lymphoma
    Meeting Abstract

    Kil, S. H.; Estephan, R.; Sanchez, J.; Zain, J. M.; Kadin, M. E.; Young, J. W.; Rosen, S. T.; Querfeld, C.
    Blood (2017)

    Fulltext@MSK | Save
  • In vitro, in vivo, and parallel phase I evidence support the safety and activity of duvelisib, a PI3K-δ,γ inhibitor, in combination with romidepsin or bortezomib in relapsed/refractory T-cell lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Koch, R.; Mehta-Shah, N.; Myskowski, P.; Kheterpal, M.; Dogan, A.; Davey, T.; Galasso, N.; Evan, M.; Shah, M.; more...
    Blood (2017)

    Fulltext@MSK | Save